Tim Ammon studied biology with a focus on cell biology and infection biology at Philipps-Universität Marburg. After graduating, he successfully conducted research on ubiquitin-like proteins, pre-mRNA processing and DNA repair as part of his doctoral thesis in the laboratory of Prof. Stefan Jentsch at the Max Planck Institute of Biochemistry in Martinsried. Tim then moved into translational research and worked as a postdoc in the lab of Prof. Marc Schmidt-Supprian at the TranslaTUM of the Technical University of Munich, where he investigated cell-cell communication between immune cells and their microenvironment during lymphomagenesis.
Tim joined ISAR Bioscience as a scientist in 2021 and took over the leadership of the immunology team in 2022. At ISAR Bioscience, in addition to various research projects in the field of immune cell gene therapy, he is also responsible for the development of novel methods for the production of stem cell-derived immune cells.